Delivery Order SPE2DB22D1202-SPE2DB25FUSZ5

Award Date 2/14/25
Potential Completion Date 2/18/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension. The contract has a ceiling value of $2,688.86 and a period of performance through January 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml oral suspension in 60 ml bottles. The contract has a firm fixed price of $1,524.36 and a completion date of September 11, 2024. It is not a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, with a ceiling value of $1,895.00 and a completion date of January 24, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension (120 ml), a prescription medication. The contract has a ceiling value of $2,208.70 and a period of performance through August 8, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen Drug Corp holds several Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication, and has a ceiling value of $1,577.04. The contract is a firm fixed-price Delivery Order with a completion date of January 22, 2025. The contract is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has a ceiling value of $1,051.36 and runs through January 22, 2025. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension, a specialty medication. The $1,445.62 firm fixed price contract has a completion date of November 21, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Quillivant XR 25 mg/5 ml suspension medication, with a ceiling value of $1,870.98 and a period of performance through August 2024. The contract is structured as a firm fixed price delivery order, without any set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,768.09, is for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has a firm fixed price pricing type and runs until February 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension in 120 ml bottles. The contract has an ultimate completion date of August 25, 2023 and a ceiling value of $1,016.24. This order is placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUSZ5
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The contract has a total ceiling value of $2,343.11 and an ultimate completion date of February 18, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen, the prime contractor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/16/25, 12:29 PM